Key result
A face-to-face Acceptance and Commitment Therapy (ACT) intervention significantly reduced high-sensitivity C-reactive protein (hsCRP) levels over 36 weeks in adults with overweight and psychological distress (group × time interaction p=0.012).
Why the study?
Psychological processes can manifest in physiological health, but whether acceptance and commitment therapy influences inflammation and stress biomarkers in distressed adults with overweight or obesity was unknown.
Does acceptance and commitment therapy (ACT) reduce inflammation and stress biomarkers in working-age adults with psychological distress and overweight/obesity?
RCT (n=254)
Parallel
Yes
Does acceptance and commitment therapy (ACT) reduce inflammation and stress biomarkers in working-age adults with psychological distress and overweight/obesity?
p-value: p=0.012
Face-to-face acceptance and commitment therapy may reduce low-grade systemic inflammation (hsCRP) in overweight and obese adults with psychological distress.
May support face-to-face ACT to lower hsCRP in distressed overweight adults; extends ACT evidence to inflammatory biomarkers.
BACKGROUND: Psychological processes can be manifested in physiological health. We investigated whether acceptance and commitment therapy (ACT), targeted on psychological flexibility (PF), influences inflammation and stress biomarkers among working-age adults with psychological distress and overweight/obesity. METHOD: Participants were randomized into three parallel groups: (1) ACT-based face-to-face (n = 65; six group sessions led by a psychologist), (2) ACT-based mobile (n = 73; one group session and mobile app), and (3) control (n = 66; only the measurements). Systemic inflammation and stress markers were analyzed at baseline, at 10 weeks after the baseline (post-intervention), and at 36 weeks after the baseline (follow-up). General PF and weight-related PF were measured with questionnaires (Acceptance and Action Questionnaire, Acceptance and Action Questionnaire for Weight-Related Difficulties). RESULTS: A group × time interaction (p = .012) was detected in the high-sensitivity C-reactive protein (hsCRP) level but not in other inflammation and stress biomarkers. hsCRP decreased significantly in the face-to-face group from week 0 to week 36, and at week 36, hsCRP was lower among the participants in the face-to-face group than in the mobile group (p = .035, post hoc test). Age and sex were stronger predictors of biomarker levels at follow-up than the post-intervention PF. CONCLUSION: The results suggest that ACT delivered in group sessions may exert beneficial effects on low-grade systemic inflammation. More research is needed on how to best apply psychological interventions for the health of both mind and body among people with overweight/obesity and psychological distress. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01738256, Registered 17 August, 2012.
No takes yet. Share an insight, caveat, or question.
Järvelä‐Reijonen et al. (2020) conducted an RCT in Psychological distress and overweight/obesity (n=254). Acceptance and Commitment Therapy (ACT) vs. No-treatment control was evaluated on Systemic inflammation and stress markers (hsCRP, IL-1Ra, HMW adiponectin, cortisol, DHEAS) (p=0.012). A face-to-face Acceptance and Commitment Therapy (ACT) intervention significantly reduced high-sensitivity C-reactive protein (hsCRP) levels over 36 weeks in adults with overweight and psychological distress (group × time interaction p=0.012).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: